Bookmark

Add to MyYahoo RSS

Hepatitis News

News on Hepatitis continually updated from thousands of sources around the net.

8 hrs ago | CiteULike

West Nile virus drug discovery.

The outbreak of West Nile virus in 1999 in the USA, and its continued spread throughout the Americas, parts of Europe, the Middle East and Africa, underscored the need for WNV antiviral development. Here, we review the current status of WNV drug discovery.

Comment?

Related Topix: Health, West Nile Virus, Medicine

16 hrs ago | The Peninsula

Workers to be screened for hepatitis at home

DOHA: Foreign workers seeking employment in Qatar will have to screen for hepatitis in their home countries starting from end of this year, according to a senior official. Pre-arrival test for hepatitis will be part of a compulsory medical screening for some chronic diseases.

Comment?

Related Topix: Medicine, Health, Qatar, Middle East, World News

16 hrs ago | Medical Daily

Gilead To Raise Price For New Hepatitis C Drug Above $84,000

The next generation version of Gilead Sciences Inc's $84,000 hepatitis C drug, already under fire for its record-breaking costs, is going to be even more expensive. Gregg Alton, Gilead's executive vice president of corporate and medical affairs, declined to give an exact price for the new medicine, the first all-oral treatment for the virus which is expected to launch next month.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Health, Startups, Health Insurance

16 hrs ago | The Peninsula

HMC survey finds 2pc hepatitis C prevalence

Abdul Basit By Fazeena Saleem DOHA: Some two percent of people screened in a random survey by Hamad Medical Corporation were diagnosed with hepatitis C viral infection. Among them 79 percent were Egyptian, 4.7 percent were Qatari, eight percent were Pakistani and eight percent were others.

Comment?

Related Topix: Medicine, Health, Centers for Disease Control and Prevention, Gastroenterology, World News, Qatar, Middle East

17 hrs ago | Newkerala.com

New 'miracle' drug eliminates Hepatitis C virus in up to 98 pc patients

Scientists have revealed that a new, which will be soon available on the NHS, has been shown to eliminate the virus per cent of patients. Specialists say the drug Daklinza, will also stem the huge rise in cases of serious liver A disease and cancer caused by the condition but it still needs to be tested on certain types of hepatitis C but has proved successful on those for which it has been prescribed, the Daily Express reported.

Comment?

Related Topix: Medicine, Health

Sat Sep 13, 2014

The Peninsula

Workers to be screened for hepatitis at home

DOHA: Foreign workers seeking employment in Qatar will have to screen for hepatitis in their home countries starting from end of this year, according to a senior official. Pre-arrival test for hepatitis will be part of a compulsory medical screening for some chronic diseases.

Comment?

Related Topix: Medicine, Health, Qatar, Middle East, World News

PR-inside.com

Hualan Biological Engineering, Inc. (002007) - Pharmaceuticals &...

The company research, develops, produces and commercializes human blood products, viral vaccines, bacterial vaccines, and recombinant biologics. Its blood products include human albumin, human immunoglobulin, human immunoglobuin for intravenous injection, human rabies immunoglobuin, human hepatitis B immunoglobulin, human tetanus immunoglobulin, human prothrombin complex, human coagulation factor VIII, and surgical lyophilized fibrin sealant.

Comment?

Related Topix: Medicine, Health, Influenza, World News, China

In-depth Africa

Darfur displaced cry out for 'urgent international help'

The Darfur Displaced and Refugees Association has called on the international community to access the camps, and investigate the various diseases spreading in the camps for the displaced in the region. "The displaced have become desperate.

Comment?

Related Topix: Health

Fri Sep 12, 2014

Ghanamma.com

Hepatitis B: Screening Of 30 Boxers At Bukom

The Theobald Hepatitis B Foundation and Hepatitis Coalition of Ghana on Friday, September 12, 2014 screened 30 boxers at Bukom. The President of the Foundation and Coalition, Mr. Theobald Owusu-Ansah educated the boxers on the nature of the disease before the screening.

Comment?

Related Topix: Medicine, Health

The Oregonian

Clash between state, drugmaker heats up as Legislature takes up Hepatitis C cost

The whopping price tag of a promising new drug-- $1,000 a pill -- that could help an estimated 95,000 sick Oregonians has the state and commercial insurers balking at coverage. Gilead Sciences wants to sell more Sovaldi, a new drug hailed as a near-miracle cure for the sometimes-fatal Hepatitis C. But citing the 12-week treatment cost of $84,000 , Oregon officials want to put strict new restrictions on access to the drug, especially for those in earlier stages of the disease.

Comment?

Related Topix: Drugs, Medicine, Health, Oregon, Biotech, Gilead Sciences, Healthcare Industry, Startups, Oregon Government

AlertNet

Gilead to raise price for new hepatitis C drug above $84,000

The next generation version of Gilead Sciences Inc's $84,000 hepatitis C drug, already under fire for its record-breaking costs, is going to be even more expensive. Gregg Alton, Gilead's executive vice president of corporate and medical affairs, declined to give an exact price for the new medicine, the first all-oral treatment for the virus which is expected to launch next month.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Startups

HIV and Hepatitis

ICAAC 2014: AbbVie 3D Hepatitis C Regimen Is Well-Tolerated in Phase 3 Trials

AbbVie's 3D hepatitis C regimen containing ABT-450, ombitasvir, and dasabuvir was generally well-tolerated in the Phase 3 SAPPHIRE trials, according to a pooled analysis presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy last week in Washington, DC. While most patients experienced some adverse events, serious side effects were rare and few people discontinued treatment early for this reason.

Comment?

Related Topix: Medicine, Health

HIV and Hepatitis

Simeprevir Label Adds Interactions with Transplant Rejection Drugs

The U.S. Food and Drug Administration recently approved revisions to the product label information for Janssen's new hepatitis C protease inhibitor simeprevir , noting drug interactions with cyclosporine and tacrolimus, which are used to prevent organ rejection after a transplant. Over years or decades, chronic hepatitis C virus infection can lead to severe liver damage that necessitates a liver transplant.

Comment?

Related Topix: Food and Drug Administration, Medicine, Health, Cyclosporine (generic), Neoral, Pharmacology

Forbes.com

Retrophin, Gilead, And Our Healthcare Values

Steve Brozak is President of WBB Securities, LLC, an investment bank and research firm that specializes in the biotechnology, specialty pharmaceutical and medical device sectors. Mr. Brozak is an award winning analyst whose research has been singled out from his peers for accuracy and performance year after year by the financial industry's most highly regarded rankings organizations.

Comment?

Related Topix: Biotech, Science / Technology, US Military, US Marine Corps, US News, US Navy, Medicine, Health

The BIG One

Patients Face Possible Hepatitis B Exposure

More than a dozen patients at a Cleveland hospital are being told of a possible exposure to Hepatitis B. Cleveland Clinic officials say an error in sterilizing dialysis equipment after treating a Hepatitis B-infected patient last month at Fairview Hospital may have put other patients at risk.

Comment?

Related Topix: Medicine, Health

Centers for Disease Control and Preve...

Notifiable Diseases and Mortality Tables

Table I Summary of provisional cases of selected notifiable diseases, United States, cumulative, week ending September 6, 2014 Figure I Selected notifiable disease reports, United States, comparison of provisional 4-week totals ending September 6, 2014, with historical data Table II Provisional cases of selected notifiable diseases, United States, weeks ending September 6, 2014 and September 7, 2013 TABLE I. Provisional cases of infrequently reported notifiable diseases (100,000. A death is reported by the place of its occurrence and by the week that the death certificate was filed.

Comment?

Related Topix: Centers for Disease Control and Prevention

Thu Sep 11, 2014

BioSpace

AASLD / EASL Special Conference On Hepatitis C, Sheraton New York...

Members of the media interested in attending the conference may apply for a press pass by submitting their registration request and credential information to as we discuss two major developmentsthe recommendation for birth cohort screening and the recent approval of all-oral treatment regimensthat are poised to change the landscape of HCV patient care. This special conference brings together a distinguished faculty from around the world to discuss the pathogenesis, diagnosis, and treatment of the disease.

Comment?

Related Topix: Medicine, Health

GastroHep.com

Metabolic syndrome delays HBeAg seroclearance in patients with hepatitis B

Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B, reports the latest issue of the Alimentary Pharmacology & Therapeutics. The patients were classified into 3 groups according to the metabolic characteristics including normal, pre-MetS and MetS based on the International Diabetes Federation criteria.

Comment?

Related Topix: Metabolic Syndrome, Health, Medicine, Pharmacology, Diabetes

R & D

New defense mechanism against viruses discovered

When it comes to defense against viruses, the immune system has an arsenal of weapons at its disposal including killer cells, antibodies and messenger molecules, to name just a few. When a pathogen attacks the body, the immune system usually activates the appropriate mechanisms.

Comment?

Related Topix: Medicine, Health, tick, Biology, Science

Seeking Alpha

Gilead Will Continue To Rise

Fundamentals of the company will continue to improve with growing Sovaldi sales and the launch of Zydlig, Gilead's first Cancer drug. Gilead Sciences has experienced massive success from its signature drug, Sovaldi, used for the treatment of Hepatitis-C Virus [HCV] - the drug continues to bring substantial profitability to the company.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Startups, Health, Medicaid

•••
•••
•••
•••
•••
•••
•••
•••